Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...
It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...
Zacks.com on MSN
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest close session, CRISPR Therapeutics AG (CRSP) was down 5.82% at $54.00. The stock trailed the S&P 500, which registered a daily gain of 0.58%. Meanwhile, the Dow experienced a rise of ...
Billionaire investor Cathie Wood, through her ARK ETFs, made big buys of CRISPR Therapeutics on Friday, Oct. 9, and Monday, ...
The company's expertise in gene editing could lead to more breakthroughs.
Evergreen sectors are always a great starting point. These are industries that never go out of style. Take healthcare stocks, for example. People will always need care, and there's always a push to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results